1.
Suttichaimongkol T, Mitpracha M, Tangvoraphonkchai K, Sadeea P, Sawanyawisuth K, Sukeepaisarnjaroen W. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. J Circ Biomark [Internet]. 2023 Feb. 17 [cited 2024 Jun. 17];12(1):12-6. Available from: https://journals.aboutscience.eu/index.php/jcb/article/view/2453